#ASGCT26: A Zillow-like marketplace for abandoned gene therapies goes livenews2026-05-15T10:45:33+00:00May 15th, 2026|Endpoints News|
Supreme Court preserves mail access for abortion pillnews2026-05-15T07:21:52+00:00May 15th, 2026|Endpoints News|
Encoded’s gene therapy reduced seizures in Dravet syndromenews2026-05-14T18:50:34+00:00May 14th, 2026|Endpoints News|
ASGCT dispatch: In vivo CAR-T is everywherenews2026-05-14T18:24:17+00:00May 14th, 2026|Endpoints News|
Drugmakers have to go through rigorous tests to get a lower tariff ratenews2026-05-14T16:00:16+00:00May 14th, 2026|Endpoints News|
Degron, CREATE, TenNor raise capital; Cabaletta posts CAR-T datanews2026-05-14T14:42:33+00:00May 14th, 2026|Endpoints News|
AstraZeneca follows Merck with Phase 3 win in bladder cancernews2026-05-14T14:31:59+00:00May 14th, 2026|Endpoints News|
MacroGenics sells manufacturing arm; West Pharma discloses cybersecurity attacknews2026-05-14T14:10:18+00:00May 14th, 2026|Endpoints News|
How Penn Medicine plans to use AI to train their doctorsnews2026-05-14T13:00:56+00:00May 14th, 2026|Endpoints News|
Biogen’s anti-tau Alzheimer’s drug misses Phase 2 goal, but claims signs of efficacynews2026-05-14T11:32:28+00:00May 14th, 2026|Endpoints News|
